What is Atazanavir (ATV)?

Category: Prescription Drugs

Most popular types: Reyataz

false

See also: Evotaz

Atazanavir is a protease inhibitor used in the treatment of HIV-1 infections in combination with at least two other antiretroviral agents. In patients with prior virologic failure, coadministration with ritonavir is recommended.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Human immunodeficiency virus (HIV) 296 71
General health 6 8
Support immune health 2 5
Fatigue 1 0
Improve communication 1 0

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 4
Moderate 20
Mild 19
None 30

Commonly reported side effects and conditions associated with Atazanavir (ATV)

Side effect Patients Percentage
Fatigue 4
Jaundice 4
Yellow eyes 4
Abdominal cramps 2
Diarrhea 2
Digestive problems 2

Show all 19 reported side effects

Why patients stopped taking Atazanavir (ATV)

Multiple reasons could be selected

Reason Patients Percentage
Doctor's advice 22
Side effects too severe 17
Other 12
Course of treatment ended 2
Did not seem to work 2
Change in health plan coverage 1
Expense 1
Personal research 1
See all 51 patients who've stopped taking Atazanavir (ATV)

Duration

Stopped taking Atazanavir (ATV)

Duration Patients Percentage
Less than 1 month 4
1 - 6 months 9
6 months - 1 year 8
1 - 2 years 9
2 - 5 years 10
5 - 10 years 6
10 years or more 1
Adherence
Adherence Evaluations Percentage
Always 59
Usually 8
Sometimes 4
Never taken as prescribed 2
Burden
Burden Evaluations Percentage
Very hard to take 1
Somewhat hard to take 4
A little hard to take 14
Not at all hard to take 54
Cost per month
Cost per month Evaluations Percentage
$200+ 1
$100-199 0
$50-99 7
$25-49 8
< $25 34
Not specified 23

What people switch to and from

Patients started taking Atazanavir (ATV) after stopping:

Treatment Patients Percentage
Atazanavir-cobicistat (ATV/c) (Evotaz) 1
Efavirenz-Emtricitabine-Tenofovir disoproxil fumarate (Atripla) 1
Emtricitabine-Tenofovir disoproxil fumarate (Truvada) 1

Patients stopped taking Atazanavir (ATV) and switched to:

Treatment Patients Percentage
Cobicistat-elvitegravir-emtricitabine-tenofovir disoproxil (Stribild) 2
Efavirenz (EFV) (Sustiva) 1
Ritonavir (RTV, /r) (Norvir) 1
Last updated:

11 patient evaluations for Atazanavir (ATV)

Aug 18, 2014 (Started Aug 01, 2014)

  • Effectiveness
    Can't tell (for human immunodeficiency virus (HIV))
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 300 mg Daily

  • 0 helpful marks

Aug 15, 2012 (Started Apr 18, 2012)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    Moderate (jaundice)
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 300 mg Daily

  • 0 helpful marks

Aug 24, 2011 (Started May 06, 2011)

  • Effectiveness
    Moderate (for human immunodeficiency virus (HIV))
  • Side effects
    Mild
  • Adherence
    Sometimes
  • Burden
    A little hard to take
Dosage: 100 mg Daily
Cost: < $25 monthly

  • 0 helpful marks
Last updated:
Showing 3 of 11 patient evaluations for Atazanavir (ATV)